Skip to main content
. 2024 Jun 3;25(1):90. doi: 10.1186/s10194-024-01790-7

Table 2.

Number of patients receiving erenumab, fremanezumab or galcanezumab during their 1st -6th treatment cycles

1st TC 2nd TC 3rd TC 4th TC 5th TC 6th TC Total number of TCs
Erenumab 427 29 17 1 1 0 475
Fremanezumab 150 89 9 3 0 0 251
Galcanezumab 78 54 14 2 0 1 149

Number of patients receiving erenumab, fremanezumab or galcanezumab during their first to sixth treatment attempts (treatment cycles) with an anti-calcitonin gene-related peptide (-receptor) monoclonal antibody. TC: treatment cycle